Search Results - Green, Andrew

Andrew Green

Andrew Green or Andy Green may refer to:
*Andrew Green, Baron Green of Deddington (born 1941), former British diplomat and anti-immigration activist *Andrew Green (Formula One) (born 1965), Formula One engineer *Andrew Green (ghost hunter) (1927–2004), British ghost hunter *Andrew Green (Jersey politician), Deputy for St Helier 3 & 4 District, Jersey *Andrew Green (librarian), Welsh librarian *Andrew Green (MP) for Dunwich (UK Parliament constituency) *Andrew Haswell Green (1820–1903), American civic leader
*Andy Green (RAF officer) (born 1962), British land speed record driver *Andy Green (baseball) (born 1977), American baseball player and manager *Andy Green (boxer) (born 1970), English boxer *Andy Green (darts player) (born 1946), American former darts player
Provided by Wikipedia
Refine Results
  1. 1
    Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer

    Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer by Alfarsi, Lutfi, Johnston, Simon, Liu, Dong-Xu, Rakha, Emad, Green, Andrew

    Published 2018
    Get full text
  2. 2
    IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients

    IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients by Ahmad, Narmeen, Ammar, Aula, Storr, Sarah J., Green, Andrew R., Rakha, Emad, Ellis, Ian, Martin, Stewart G.

    Published 2018
    Get full text
  3. 3
    Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival

    Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival by Xuan, Pu, Storr, Sarah J., Zhang, Yimin, Rakha, Emad, Green, Andrew R., Ellis, Ian O., Martin, Stewart G.

    Published 2016
    Get full text
  4. 4
    Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations

    Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations by El Ansari, Rokaya, McIntyre, Alan, Craze, Madeleine L., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.

    Published 2017
    Get full text
  5. 5
    High nuclear MSK1 is associated with longer survival in breast cancer patients

    High nuclear MSK1 is associated with longer survival in breast cancer patients by Pu, Xuan, Storr, Sarah J., Ahmad, Narmeen, Rakha, Emad, Green, Andrew R., Ellis, Ian O., Martin, Stewart G.

    Published 2018
    Get full text
  6. 6
    Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma

    Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma by Sonbul, Sultan N., Gorringe, Kylie L., Aleskandarany, Mohammed A., Mukherjee, Abhik, Green, Andrew R., Ellis, Ian O., Rakha, Emad A.

    Published 2017
    Get full text
  7. 7
    Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer

    Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer by Aleskandarany, Mohammed A., Green, Andrew R., Ashankyty, I., Elmouna, A., Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad

    Published 2016
    Get full text
  8. 8
    FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype

    FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype by Joseph, C., Craze, Madeleine L., Nolan, C.C., Diez-Rodriguez, Maria, Green, Andrew R., Rakha, Emad, Ellis, Ian O., Mukherjee, A.

    Published 2017
    Get full text
  9. 9
    The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

    The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes by El Ansari, Rokaya, Craze, Madeleine L., Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.

    Published 2018
    Get full text
  10. 10
    A quantifier-based fuzzy classification system for breast cancer patients

    A quantifier-based fuzzy classification system for breast cancer patients by Soria, Daniele, Garibaldi, Jonathan M., Green, Andrew R., Powe, Desmond G., Nolan, Christopher C., Lemetre, Christophe, Ball, Graham R., Ellis, Ian O.

    Published 2013
    Get full text
  11. 11
    Oestrogen receptor negative early operable primary breast cancer in older women—biological characteristics and long-term clinical outcome

    Oestrogen receptor negative early operable primary breast cancer in older women—biological characteristics and long-term clinical outcome by Coleman, William B., Syed, Binafsha Manzoor, Morgan, DAL, Setty, Tulassi, Green, Andrew R., Paish, Emma C., Ellis, Ian O., Cheung, Kwok-Leung

    Published 2017
    Get full text
  12. 12
    The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

    The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours by El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R.

    Published 2018
    Get full text
  13. 13
    Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer

    Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer by Rakha, Emad, Soria, Daniele, Green, Andrew R., Lemetre, Christophe, Powe, Desmond G., Nolan, Christopher C., Garibaldi, Jonathan M., Ball, Graham, Ellis, Ian O.

    Published 2014
    Get full text
  14. 14
    Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers

    Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers by Green, Andrew R., Aleskandarany, Mohammed A., Ali, Reem, Hodgson, Eleanor Grace, Atabani, Suha, De Souza, Karen, Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan

    Published 2017
    Get full text
  15. 15
    Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

    Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein by Alshareeda, Alaa, Negm, Ola H., Aleskandarany, Mohammed A., Green, Andrew R., Nolan, Christopher, Tighe, Patrick J., Madhusudan, Srinivasan, Ellis, Ian O., Rakha, Emad

    Published 2016
    Get full text
  16. 16
    Impact of breast cancer grade discordance on prediction of outcome

    Impact of breast cancer grade discordance on prediction of outcome by Rakha, Emad A., Aleskandarany, Mohammed A., Toss, Michael S., Mongan, Nigel, ElSayed, Maysa E., Green, Andrew R., Ellis, Ian O., Dalton, Leslie W.

    Published 2018
    Get full text
  17. 17
    Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort

    Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort by Schuil, Hugo, Derks, Marloes, Liefers, Gerrit-Jan, Portielje, Johanneke, van de Velde, Cornelis, Syed, Binafsha, Green, Andrew, Ellis, Ian, Cheung, Kwok-Leung, Bastiaannet, Esther

    Published 2018
    Get full text
  18. 18
    Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast

    Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast by Toss, Michael S., Miligy, Islam, Al-Kawaz, Abdubaqi, Alsleem, Mansour, Khout, Hazem, Rida, Padmashree C., Aneja, Ritu, Green, Andrew R., Ellis, Ian O., Rakha, Emad

    Published 2018
    Get full text
  19. 19
    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy

    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy by Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y.T., Green, Andrew R., Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan

    Published 2018
    Get full text
  20. 20
    Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

    Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers by Ahmad, Dena Akram Jerjees, Negm, Ola H., Layth Alabdullah, M., Mirza, Sameer, Hamed, Mohamed R., Band, Vimla, Green, Andrew R., Ellis, Ian O., Rakha, Emad

    Published 2016
    Get full text

Search Tools: